Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

A Study of GWP42006 in People With Focal Seizures - Part B

NCT02365610 ·Status: COMPLETED ·Phase: PHASE2

A Study of GWP42006 in People With Focal Seizures - Part A

NCT02369471 ·Status: COMPLETED ·Phase: PHASE2

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314 ·Status: COMPLETED ·Phase: PHASE1

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Precision Medicine in the Treatment of Epilepsy

NCT05450822 ·Status: RECRUITING

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 ·Status: COMPLETED ·Phase: PHASE2

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

NCT00310375 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

NCT03796962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

NCT00744731 ·Status: COMPLETED ·Phase: PHASE3

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05493293 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

NCT01268904 ·Status: UNKNOWN

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT04686786 ·Status: TERMINATED ·Phase: PHASE2

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118962 ·Status: COMPLETED ·Phase: PHASE2

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT02726919 ·Status: UNKNOWN ·Phase: PHASE4

Cortical Resections in Drug Resistant Epilepsy

NCT04553354 ·Status: UNKNOWN

Valproic AcId for Traumatic BRAin INjury Trial

NCT07166393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

NCT04557085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT04879433 ·Status: UNKNOWN

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

NCT00991757 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452 ·Status: COMPLETED ·Phase: PHASE3

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

NCT00510783 ·Status: COMPLETED ·Phase: PHASE4

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

NCT00310388 ·Status: TERMINATED ·Phase: PHASE3